SK
Sanjay Kundu
About Sanjay Kundu
Data last updated:
Sanjay Kundu is a Director at Laborate Pharmaceuticals India Ltd (since 2025). The companies operate in Pharma, Financial Services and Infrastructure and Utilities. Laborate Pharmaceuticals India Ltd reported revenue of ₹1,553 Cr (FY 2025). Earlier, Sanjay Kundu was a Director at Spec Finance (Ifsc) Private Limited (2025–2026) and Nominee Director at National Projects Construction Corporation Limited (2016–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Laborate Pharmaceuticals India Ltd U24239HR1990PLC030835 | Director | 22 May 2025 | 1990 | ₹1,553 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spec Finance (Ifsc) Private Limited U66190GJ2023PTC145068 | Director | 01 Sep 2025 | 2023 | ₹70.9 Lakh (FY 2025) | Active |
 National Projects Construction Corporation Limited U45202DL1957GOI002752 | Nominee Director | 20 Sep 2016 | 1957 | ₹1,710 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kundu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Bhatia | 00038833 | Laborate Pharmaceuticals India Ltd | Whole-Time Director |
| Arpit Bhatia | 08273255 | Laborate Pharmaceuticals India Ltd | Whole-Time Director |
| Garima Parashar | 09026164 | Laborate Pharmaceuticals India Ltd | Director |
| Parag Bhatia | 06905819 | Laborate Pharmaceuticals India Ltd | Whole-Time Director |
| Sanjay Bhatia | 00189247 | Laborate Pharmaceuticals India Ltd | Whole-Time Director |
| Sidharth Verma | 08076537 | Laborate Pharmaceuticals India Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kundu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kundu
Sanjay Kundu currently holds 1 directorship: Laborate Pharmaceuticals India Ltd (Director, since 22 May 2025, revenue ₹1,553 Cr (FY 2025)).
Sanjay Kundu was first appointed on 20 Sep 2016 as Nominee Director at National Projects Construction Corporation Limited. The most recent appointment on record is 01 Sep 2025 at Spec Finance (Ifsc) Private Limited.
Sanjay Kundu held 2 earlier board appointments: Spec Finance (Ifsc) Private Limited (Director, 01 Sep 2025 to 23 Jan 2026); National Projects Construction Corporation Limited (Nominee Director, 20 Sep 2016 to 25 May 2018).
The current boards of Sanjay Kundu's companies include Ajay Bhatia (Laborate Pharmaceuticals India Ltd), Arpit Bhatia (Laborate Pharmaceuticals India Ltd), Garima Parashar (Laborate Pharmaceuticals India Ltd), Parag Bhatia (Laborate Pharmaceuticals India Ltd), Sanjay Bhatia (Laborate Pharmaceuticals India Ltd), Sidharth Verma (Laborate Pharmaceuticals India Ltd).